Palliative Care Begins at Diagnosis, Not at End of Life Laurie Feingold, LSW December 31st 2024 "When most people hear the words palliative care, they immediately think about hospice or end-of-life care. This includes most medical professionals." ‘Keeping It Human’ When Having Difficult Conver...
Oncology practices can create more access to care by leveraging the use of APPs, empowering nurses to practice at the top of their licensure, utilizing nurse navigators, and planning ahead. Flat vector illustration portrait nurses and doctors at hospital proud empowered and excited about medical ...
For medical practices to operate efficiently, transferring patient data seamlessly into the EHR and practice management systems is essential. This transformative approach eliminates manual and burdensome steps associated with patient onboarding and consent, enabling digital form completion before the first ...
Medical Oncologist The US Oncology Network Assistant Professor of Internal Medicine University of Central Florida College of Medicine Orlando, FL Targeted Oncology: What do you feel are some of the biggest updates in precision medicine right now? DIETRICH: We’ve seen 2 major developments. One is ...
Kang, medical director of women’s health medical oncology at City of Hope Orange County in Irvine, California, said that since ADC toxicities often mirror those of chemotherapy, it’s important to recognize they can vary for each compound. Although T-DM1, which breast cancer oncologists are...
“First-line pembrolizumab as monotherapy or in combination with chemotherapy remains the standard of care for first-line treatments in patients with recurrent or metastatic [HNSCC],” Lisa Licitra, MD, a medical oncologist at Fondazione IRCCS Istituto Nazionale dei Tumori and University of Mil...
With the use of earlier CAR T-cell therapy, patients are offered the chance at deeper remissions, better long-term outcomes, and a 1-time infusion which will help the CAR T-cell benefits for patients. Additionally, the use of CAR T-cell therapy earlier also links with less ongoing exposur...
the relapsed setting. However, many patients with relapsed disease have lymphoma that is not chemotherapy sensitive. So this is not an option that works well for a good number of patients.” Zitella is a hematology/ oncology nurse practitioner at UCSF Medical Center in San Francisco, California....
Scott T. Tagawa, MD, MS, FACP, FASCO, professor of medicine and Urology at Weill Cornell Medicine, and an attending physician at NewYork-Presbyterian – Weill Cornell Medical Center, highlights a key difference between oral androgen receptor (AR) inhibitor drugs and therapeutic radionuclides for ...